NO20091970L - Krystallmodifikasjoner av 3-(1,H-indol-3-yl)-4-[2-(4-metyl-piperazin-1-yl)-quinazolin-4-yl]-pyrrol-2,5-dion - Google Patents

Krystallmodifikasjoner av 3-(1,H-indol-3-yl)-4-[2-(4-metyl-piperazin-1-yl)-quinazolin-4-yl]-pyrrol-2,5-dion

Info

Publication number
NO20091970L
NO20091970L NO20091970A NO20091970A NO20091970L NO 20091970 L NO20091970 L NO 20091970L NO 20091970 A NO20091970 A NO 20091970A NO 20091970 A NO20091970 A NO 20091970A NO 20091970 L NO20091970 L NO 20091970L
Authority
NO
Norway
Prior art keywords
quinazolin
pyrrol
piperazin
indol
dione
Prior art date
Application number
NO20091970A
Other languages
English (en)
Norwegian (no)
Inventor
Piotr Karpinski
Paul Allen Sutton
Dimitris Papoutsakis
Stephanie Monnier
Elias Ndzie
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38921707&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20091970(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20091970L publication Critical patent/NO20091970L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20091970A 2006-10-20 2009-05-20 Krystallmodifikasjoner av 3-(1,H-indol-3-yl)-4-[2-(4-metyl-piperazin-1-yl)-quinazolin-4-yl]-pyrrol-2,5-dion NO20091970L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85338406P 2006-10-20 2006-10-20
PCT/US2007/022241 WO2008051440A1 (en) 2006-10-20 2007-10-18 Crystal modifications -3- (1h-ind0l-3-yl) -4- [2- (4-methyl-piperazin-1-yl) -quinazolin-4-yl] -pyrrole-2, 5-d ione

Publications (1)

Publication Number Publication Date
NO20091970L true NO20091970L (no) 2009-05-20

Family

ID=38921707

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20091970A NO20091970L (no) 2006-10-20 2009-05-20 Krystallmodifikasjoner av 3-(1,H-indol-3-yl)-4-[2-(4-metyl-piperazin-1-yl)-quinazolin-4-yl]-pyrrol-2,5-dion

Country Status (23)

Country Link
US (1) US8865897B2 (pt)
EP (1) EP2102195A1 (pt)
JP (1) JP5302199B2 (pt)
KR (1) KR20090073231A (pt)
CN (2) CN101522664B (pt)
AR (1) AR063491A1 (pt)
AU (1) AU2007309558B2 (pt)
BR (1) BRPI0717461A2 (pt)
CA (1) CA2666965A1 (pt)
CL (1) CL2007003006A1 (pt)
EC (1) ECSP099344A (pt)
IL (1) IL197962A (pt)
MA (1) MA30886B1 (pt)
MX (1) MX2009004048A (pt)
MY (1) MY158026A (pt)
NO (1) NO20091970L (pt)
NZ (1) NZ576241A (pt)
PE (1) PE20081133A1 (pt)
RU (1) RU2481341C2 (pt)
TN (1) TN2009000147A1 (pt)
TW (1) TWI399374B (pt)
WO (1) WO2008051440A1 (pt)
ZA (1) ZA200902048B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100093749A1 (en) * 2007-03-09 2010-04-15 Novartis Ag Compounds
US9005409B2 (en) 2011-04-14 2015-04-14 Tel Nexx, Inc. Electro chemical deposition and replenishment apparatus
US9017528B2 (en) 2011-04-14 2015-04-28 Tel Nexx, Inc. Electro chemical deposition and replenishment apparatus
US9303329B2 (en) 2013-11-11 2016-04-05 Tel Nexx, Inc. Electrochemical deposition apparatus with remote catholyte fluid management

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1253449C (zh) * 2000-11-07 2006-04-26 诺瓦提斯公司 作为蛋白激酶c抑制剂的吲哚基马来酰亚胺衍生物
GB0504203D0 (en) * 2005-03-01 2005-04-06 Novartis Ag Organic compounds
MX2009013431A (es) 2007-06-18 2010-01-15 Sanofi Aventis Derivados de pirrol como antagonistas de p2y12.

Also Published As

Publication number Publication date
JP5302199B2 (ja) 2013-10-02
MX2009004048A (es) 2009-04-27
IL197962A0 (en) 2009-12-24
US20100041884A1 (en) 2010-02-18
MA30886B1 (fr) 2009-11-02
RU2481341C2 (ru) 2013-05-10
IL197962A (en) 2013-08-29
BRPI0717461A2 (pt) 2013-10-08
CN103265533A (zh) 2013-08-28
PE20081133A1 (es) 2008-09-16
ZA200902048B (en) 2010-01-27
AU2007309558B2 (en) 2012-05-24
CA2666965A1 (en) 2008-05-02
TW200829572A (en) 2008-07-16
KR20090073231A (ko) 2009-07-02
JP2010506927A (ja) 2010-03-04
TN2009000147A1 (en) 2010-10-18
CN101522664A (zh) 2009-09-02
US8865897B2 (en) 2014-10-21
ECSP099344A (es) 2009-06-30
EP2102195A1 (en) 2009-09-23
NZ576241A (en) 2012-05-25
TWI399374B (zh) 2013-06-21
AR063491A1 (es) 2009-01-28
RU2009118816A (ru) 2010-11-27
CL2007003006A1 (es) 2008-05-23
WO2008051440A1 (en) 2008-05-02
CN101522664B (zh) 2013-06-12
MY158026A (en) 2016-08-30
AU2007309558A1 (en) 2008-05-02

Similar Documents

Publication Publication Date Title
MX2022009998A (es) Formas cristalinas de la n-(4-(4-(ciclopropilmetil)piperazin-1- carbonil)fenil)quinolin-8-sulfonamida.
CY1119624T1 (el) Κρυσταλλικες μορφες του 4-μεθυλο-ν-[3-(4-μεθυλ-ιμιδαζολ-1-υλ)-5-τριφθορομεθυλο-φαινυλο] -3 -(4-πυριδιν-3-υλ-πυριμιδιν-2-υλαμινο)-βενζαμιδιου
MX2009002229A (es) Benzotriazoles como moduladores de cinasas.
EA201001005A1 (ru) Производные 2-бензилпиридазинона в качестве ингибиторов мет киназы
EA201000093A1 (ru) Производные пиридазинона
ATE479687T1 (de) Kinaseinhibitoren
NO20075987L (no) Bisykliske derviater som p38-kinaseinhibitorer
DOP2013000072A (es) ((r)-(e)-2-(4-(2-(5-(1-(3,5-dicloropiridin-4-il)etoxi)-1h-indazol-3-il)-1h-indazol-3-il)vinil)-1h-pirazol-1-il)etanol cristalino.
WO2008017361A3 (de) 2-(heterocyclylbenzyl)-pyridazinonderivate
MX2009012595A (es) Derivados de espiroindolinona.
NO20084912L (no) Bisykliske derivater som CETP-inhibitorer
EA200970019A1 (ru) Кристаллические формы 4-[2-(4-метилфенилсульфанил)фенил]пиперидина с объединенным ингибированием повторного поглощения серотонина и норадреналина для лечения невропатической боли
EA201100966A1 (ru) Производные пиридазинона
TW200722421A (en) Azole derivatives as inhibitors of lipases and phospholipases
BR112015007937A2 (pt) formas cristalinas de um inibidor de fator xia
NO20082096L (no) Azaindol-2-karboksamidderivativer
EA201100872A1 (ru) Производные хиназолинамида
NO20075275L (no) Nye forbindelser
HK1222396A1 (zh) 作为选择性蛋白质激酶抑制剂之苯并咪唑衍生物
EA201100031A1 (ru) 3-(3-пиримидин-2-илбензил)-1,2,4-триазоло[4,3-b]пиридазин производные в качестве ингибиторов мет киназы
ATE542800T1 (de) Kinasehemmer und ihre anwendungsverfahren
ATE553106T1 (de) Heteroarylpyrrolopyridinone als kinaseinhibitoren
WO2007087419A3 (en) Substituted 3-(5-membered unsaturated heterocyclyl) -1, 3-dihydro-indol-2-one derivatives as tyrosine kinase inhibitors for the treatment of cancer
NO20083269L (no) Prosess for a anvende krystallinsk orlistatmetoder
NO20080034L (no) Benzotiazol-2-on derivater som lipase og fosfolipaseinhibitorer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application